Cresilon
Cresilon is a Brooklyn-based biotech company dedicated to saving lives through innovative hemostatic solutions. Their mission is to provide safe, effective, and reliable products that stop bleeding quickly, utilizing plant-based technology to revolutionize wound care in both veterinary and human medicine.
Cresilon
What We Do
A single-use, prescription hemostatic gel for veterinary use that helps control bleeding in animals by achieving hemostasis in seconds.
A hemostatic gel for temporary external use to control moderate to severe bleeding, designed for use in emergency situations.
The first hemostatic gel for the veterinary market that stops bleeding in seconds, made from plant-based polymers.
An algae-based gel that creates a mechanical barrier against bleeding, approved for use by the FDA for severe bleeding control.
Battlefield Resuscitation
Key People
News & Updates
An interview with Joe Landolina discussing the impact of Cresilon's innovations in hemostatic technology.
Coverage of the FDA approval for TRAUMAGEL, highlighting its potential to save lives in emergency situations.
A report on TRAUMAGEL and its expected impact on emergency care and trauma treatment.
Cresilon received FDA clearance for TRAUMAGEL, a hemostatic gel designed to stop severe bleeding in seconds.